利妥昔单抗成功治疗难治性成人斯蒂尔病 - Suppr

Suppr

超能文献

Successful treatment of refractory adult onset Still's disease with rituximab.

作者信息

Ahmadi-Simab K, Lamprecht P, Jankowiak C, Gross W L

出版信息

Ann Rheum Dis. 2006 Aug;65(8):1117-8. doi: 10.1136/ard.2005.047621.

DOI:10.1136/ard.2005.047621

PMID:16837497

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1798247/

Abstract

摘要

相似文献

Successful treatment of refractory adult onset Still's disease with rituximab.

Ann Rheum Dis. 2006 Aug;65(8):1117-8. doi: 10.1136/ard.2005.047621.

Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody.

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):888-9.

Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.

Ann Rheum Dis. 2011 Feb;70(2):390-2. doi: 10.1136/ard.2010.129403. Epub 2010 Jul 22.

Rituximab for refractory adult-onset Still's disease with thrombotic microangiopathy.

Rheumatology (Oxford). 2014 Sep;53(9):1717-8. doi: 10.1093/rheumatology/keu027. Epub 2014 Mar 18.

Rituximab treatment for pulmonary arterial hypertension in adult-onset Still's disease.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):657-8. Epub 2013 Apr 22.

Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease.

Arthritis Rheum. 2002 Dec;46(12):3388-9. doi: 10.1002/art.10620.

IL-1 Trap rilonacept in refractory adult onset Still's disease.

Ann Rheum Dis. 2012 Dec;71(12):2056-7. doi: 10.1136/annrheumdis-2012-201409. Epub 2012 Jun 7.

[Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):130-2. doi: 10.2169/naika.99.130.

Prolonged efficacy of infliximab for refractory adult-onset Still's disease.

Clin Exp Rheumatol. 2005 Jan-Feb;23(1):121-2.

Tocilizumab for multirefractory adult-onset Still's disease.

Ann Rheum Dis. 2009 Jan;68(1):153-4. doi: 10.1136/ard.2008.088179.

引用本文的文献

Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders.

Clin Rev Allergy Immunol. 2025 May 6;68(1):48. doi: 10.1007/s12016-025-09056-z.

Adult-Onset Still's Disease (AOSD)-On the Basis of Own Cases.

Biomedicines. 2024 Sep 10;12(9):2067. doi: 10.3390/biomedicines12092067.

Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.

Drugs. 2024 Mar;84(3):257-274. doi: 10.1007/s40265-024-01993-x. Epub 2024 Mar 5.

B cell subsets in adult-onset Still's disease: potential candidates for disease pathogenesis and immunophenotyping.

Arthritis Res Ther. 2023 Jun 15;25(1):104. doi: 10.1186/s13075-023-03070-2.

Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.

Int J Mol Sci. 2022 Oct 24;23(21):12810. doi: 10.3390/ijms232112810.

Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.

Front Med (Lausanne). 2022 Aug 22;9:881431. doi: 10.3389/fmed.2022.881431. eCollection 2022.

Progress in Biological Therapies for Adult-Onset Still's Disease.

Biologics. 2022 Apr 21;16:21-34. doi: 10.2147/BTT.S290329. eCollection 2022.

A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on Prognosis.

Front Med (Lausanne). 2020 Dec 23;7:621005. doi: 10.3389/fmed.2020.621005. eCollection 2020.

Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.

Arthritis Res Ther. 2019 Feb 12;21(1):53. doi: 10.1186/s13075-019-1838-6.

Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Drugs. 2018 Aug;78(12):1187-1195. doi: 10.1007/s40265-018-0956-9.

本文引用的文献

Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?

Ann Rheum Dis. 2005 Oct;64(10):1523-4. doi: 10.1136/ard.2005.042945. Epub 2005 Jul 13.

Rapid responses to anakinra in patients with refractory adult-onset Still's disease.

Arthritis Rheum. 2005 Jun;52(6):1794-803. doi: 10.1002/art.21061.

Clinical manifestations, disease course, and complications of adult-onset Still's disease in Taiwan.

J Formos Med Assoc. 2004 Nov;103(11):844-52.

Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

J Rheumatol. 2004 Nov;31(11):2189-98.

Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy.

J Clin Pathol. 2004 Oct;57(10):1052-6. doi: 10.1136/jcp.2004.018010.

Septicemia with Staphylococcus aureus, beta-hemolytic streptococci group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra).

J Rheumatol. 2004 Sep;31(9):1876.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

N Engl J Med. 2004 Jun 17;350(25):2572-81. doi: 10.1056/NEJMoa032534.

Lymphadenopathy in adult-onset Still's disease mimicking peripheral T-cell lymphoma.

Clin Rheumatol. 2004 Feb;23(1):81-2. doi: 10.1007/s10067-003-0826-y. Epub 2003 Dec 20.

A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma.

Lupus. 2000;9(6):468-70. doi: 10.1191/096120300678828514.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment of refractory adult onset Still's disease with rituximab.

作者信息

Ahmadi-Simab K, Lamprecht P, Jankowiak C, Gross W L

出版信息

Ann Rheum Dis. 2006 Aug;65(8):1117-8. doi: 10.1136/ard.2005.047621.

DOI:10.1136/ard.2005.047621

PMID:16837497

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1798247/

Abstract

摘要

相似文献

Successful treatment of refractory adult onset Still's disease with rituximab.

Ann Rheum Dis. 2006 Aug;65(8):1117-8. doi: 10.1136/ard.2005.047621.

Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody.

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):888-9.

Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.

Ann Rheum Dis. 2011 Feb;70(2):390-2. doi: 10.1136/ard.2010.129403. Epub 2010 Jul 22.

Rituximab for refractory adult-onset Still's disease with thrombotic microangiopathy.

Rheumatology (Oxford). 2014 Sep;53(9):1717-8. doi: 10.1093/rheumatology/keu027. Epub 2014 Mar 18.

Rituximab treatment for pulmonary arterial hypertension in adult-onset Still's disease.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):657-8. Epub 2013 Apr 22.

Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease.

Arthritis Rheum. 2002 Dec;46(12):3388-9. doi: 10.1002/art.10620.

IL-1 Trap rilonacept in refractory adult onset Still's disease.

Ann Rheum Dis. 2012 Dec;71(12):2056-7. doi: 10.1136/annrheumdis-2012-201409. Epub 2012 Jun 7.

[Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):130-2. doi: 10.2169/naika.99.130.

Prolonged efficacy of infliximab for refractory adult-onset Still's disease.

Clin Exp Rheumatol. 2005 Jan-Feb;23(1):121-2.

Tocilizumab for multirefractory adult-onset Still's disease.

Ann Rheum Dis. 2009 Jan;68(1):153-4. doi: 10.1136/ard.2008.088179.

引用本文的文献

Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders.

Clin Rev Allergy Immunol. 2025 May 6;68(1):48. doi: 10.1007/s12016-025-09056-z.

Adult-Onset Still's Disease (AOSD)-On the Basis of Own Cases.

Biomedicines. 2024 Sep 10;12(9):2067. doi: 10.3390/biomedicines12092067.

Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.

Drugs. 2024 Mar;84(3):257-274. doi: 10.1007/s40265-024-01993-x. Epub 2024 Mar 5.

B cell subsets in adult-onset Still's disease: potential candidates for disease pathogenesis and immunophenotyping.

Arthritis Res Ther. 2023 Jun 15;25(1):104. doi: 10.1186/s13075-023-03070-2.

Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.

Int J Mol Sci. 2022 Oct 24;23(21):12810. doi: 10.3390/ijms232112810.

Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.

Front Med (Lausanne). 2022 Aug 22;9:881431. doi: 10.3389/fmed.2022.881431. eCollection 2022.

Progress in Biological Therapies for Adult-Onset Still's Disease.

Biologics. 2022 Apr 21;16:21-34. doi: 10.2147/BTT.S290329. eCollection 2022.

A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on Prognosis.

Front Med (Lausanne). 2020 Dec 23;7:621005. doi: 10.3389/fmed.2020.621005. eCollection 2020.

Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.

Arthritis Res Ther. 2019 Feb 12;21(1):53. doi: 10.1186/s13075-019-1838-6.

Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Drugs. 2018 Aug;78(12):1187-1195. doi: 10.1007/s40265-018-0956-9.

本文引用的文献

Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?

Ann Rheum Dis. 2005 Oct;64(10):1523-4. doi: 10.1136/ard.2005.042945. Epub 2005 Jul 13.

Rapid responses to anakinra in patients with refractory adult-onset Still's disease.

Arthritis Rheum. 2005 Jun;52(6):1794-803. doi: 10.1002/art.21061.

Clinical manifestations, disease course, and complications of adult-onset Still's disease in Taiwan.

J Formos Med Assoc. 2004 Nov;103(11):844-52.

Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

J Rheumatol. 2004 Nov;31(11):2189-98.

Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy.

J Clin Pathol. 2004 Oct;57(10):1052-6. doi: 10.1136/jcp.2004.018010.

J Rheumatol. 2004 Sep;31(9):1876.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

N Engl J Med. 2004 Jun 17;350(25):2572-81. doi: 10.1056/NEJMoa032534.

Lymphadenopathy in adult-onset Still's disease mimicking peripheral T-cell lymphoma.

Clin Rheumatol. 2004 Feb;23(1):81-2. doi: 10.1007/s10067-003-0826-y. Epub 2003 Dec 20.

A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma.

Lupus. 2000;9(6):468-70. doi: 10.1191/096120300678828514.